The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Corvus and its shareholders are fortunate to have Ron in this strategic role as we advance the Company’s Nevada gold assets.” Ron Largent, Executive Chairman of Corvus, said, “Corvus has two excellent ...

Corvus Pharmaceuticals develops immuno-oncology therapies, with a clinical pipeline focused on monoclonal antibodies and small molecule inhibitors targeting cancer and immune disorders. The company ...

Shares of Corvus Pharmaceuticals CRVS have skyrocketed 208.8% in a month. The massive stock price rally was observed after the company announced positive results from cohort 4 of an early-stage study ...

CEO Richard A. Miller stated the company's main focus remains the development of soquelitinib for atopic dermatitis, highlighting "an oral medication featuring a novel mechanism of action that so far ...

Corvus' lead asset soquelitinib shows promise in both oncology and autoimmune - Phase 3 PTCL data and AD trial updates are key upcoming catalysts. The company faces high risk due to limited cash, ...

Shares of Corvus Pharmaceuticals (CRVS) spiked on Friday after Goldman Sachs launched its coverage with a Buy recommendation and a $40 target, calling the biotech’s lead candidate, soquelitinib, a ...

"Corvus Robotics fits our mission to invest in companies that truly transform the way business is conducted," said Marc Tarpenning, co-founder of Tesla and partner at Spero Ventures. "Other than a ...

Corvus Robotics, a provider of autonomous inventory management systems, announced an updated version of its Corvus One system. This allows the company to fly its drone-powered system in a lights-out ...

The cyber insurance industry is likely to go mainstream and is a simple cost of doing business. Here are a few options to consider. Read now Corvus Insurance, a company focused on applying artificial ...